Section 33C of DCA : Section 33C: Ayurvedic And Unani Drugs Technical Advisory Board
DCA
JavaScript did not load properly
Some content might be missing or broken. Please try disabling content blockers or use a different browser like Chrome, Safari or Firefox.
Explanation using Example
Imagine a pharmaceutical company in India plans to launch a new Ayurvedic medicine. Before the product can be brought to market, it must comply with the regulations set by the Drugs and Cosmetics Act, 1940. The company's research and development team has created a formulation that they believe is effective and safe for public use.
However, to ensure that the product meets the necessary standards, the company must seek guidance and approval from the Ayurvedic and Unani Drugs Technical Advisory Board established under Section 33C of the Act...
Login to access all pages and read more content.
To disable ads and read rest of the premium content, subscribe to KanoonGPT Pro.
KanoonGPT is now faster and smarter, powered by upgraded servers.
Subscribe today and unlock all new features!